Literature DB >> 25210563

Vas deferens invasion: A neglected issue in the sampling of radical prostatectomy materials.

Nuri Yigit1, Yildirim Karslioglu1, Bulent Kurt1.   

Abstract

A radical prostatectomy affects the prostate, bilateral seminal vesicles (SV), and the distal parts of the bilateral vasa deferentia (VD). SV invasion (SVI) is associated with an increased risk of lymph node metastasis and recurrence. However, the significance of VD invasion (VDI), either with or without the involvement of their surgical margins, has not been fully appreciated. We think VDI might have an independent prognostic significance, as does SVI, and should be incorporated into the pathology guidelines and the staging systems of prostatic adenocarcinoma. Our case illustrates this.

Entities:  

Year:  2014        PMID: 25210563      PMCID: PMC4137025          DOI: 10.5489/cuaj.1802

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  14 in total

1.  Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?

Authors:  Pia Bader; Fiona C Burkhard; Regula Markwalder; Urs E Studer
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

Review 2.  International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes.

Authors:  Daniel M Berney; Thomas M Wheeler; David J Grignon; Jonathan I Epstein; David F Griffiths; Peter A Humphrey; Theo van der Kwast; Rodolfo Montironi; Brett Delahunt; Lars Egevad; John R Srigley
Journal:  Mod Pathol       Date:  2010-09-03       Impact factor: 7.842

3.  Seminal vesicle invasion in radical prostatectomies: which is the most common route of invasion?

Authors:  Athanase Billis; Daniel A Teixeira; Rafael F Stelini; Maísa M Quintal; Marbele S Guimarães; Ubirajara Ferreira
Journal:  Int Urol Nephrol       Date:  2007-03-13       Impact factor: 2.370

4.  Protocol for the examination of specimens from patients with carcinoma of the prostate gland.

Authors:  John R Srigley; Peter A Humphrey; Mahul B Amin; Sam S Chang; Lars Egevad; Jonathan I Epstein; David J Grignon; James M McKiernan; Rodolfo Montironi; Andrew A Renshaw; Victor E Reuter; Thomas M Wheeler
Journal:  Arch Pathol Lab Med       Date:  2009-10       Impact factor: 5.534

5.  Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate cancer: prognostic stratification of pt3b disease by nodal and margin status.

Authors:  Timothy A Masterson; Joseph A Pettus; Richard G Middleton; Robert A Stephenson
Journal:  Urology       Date:  2005-07       Impact factor: 2.649

6.  Seminal vesicle invasion: what is the best adjuvant treatment after radical prostatectomy?

Authors:  Cyrille Bastide; Dominique Rossi; Eric Lechevallier; Franck Bladou; David Barriol; Denis Bretheau; Vincent Grisoni; Julien Mancini; Sophie Giusiano; Christophe Eghazarian; Antoine Van Hove
Journal:  BJU Int       Date:  2011-08-18       Impact factor: 5.588

7.  Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters.

Authors:  J I Epstein; A W Partin; S R Potter; P C Walsh
Journal:  Urology       Date:  2000-08-01       Impact factor: 2.649

Review 8.  Imaging of the seminal vesicle and vas deferens.

Authors:  Bohyun Kim; Akira Kawashima; Jeong-Ah Ryu; Naoki Takahashi; Robert P Hartman; Bernard F King
Journal:  Radiographics       Date:  2009 Jul-Aug       Impact factor: 5.333

9.  Prognostic significance of patterns of seminal vesicle invasion in prostate cancer.

Authors:  Anna Kristiansen; Fredrik Wiklund; Peter Wiklund; Lars Egevad
Journal:  Histopathology       Date:  2013-04-09       Impact factor: 5.087

10.  Local recurrence after retropubic radical prostatectomy for prostate cancer does not exclusively occur at the anastomotic site.

Authors:  Daniel P Nguyen; Gianluca Giannarini; Roland Seiler; Rike Schiller; Harriet C Thoeny; George N Thalmann; Urs E Studer
Journal:  BJU Int       Date:  2012-11-27       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.